Skip to main content
Journal cover image

Factors Related to Biologic Adherence and Outcomes Among Moderate-to-Severe Asthma Patients.

Publication ,  Journal Article
Osazuwa-Peters, OL; Greiner, MA; Oberle, A; Oakes, M; Thomas, SM; Bosworth, H
Published in: J Allergy Clin Immunol Pract
September 2022

BACKGROUND: Adherence barriers to asthma biologics may not be uniform across administration settings for patients with moderate-to-severe asthma. OBJECTIVE: To examine differences in asthma biologic adherence and associated factors, as well as association with a 1-year all-cause emergency department (ED) visit, across administration settings. METHODS: A retrospective study of biologic naïve moderate-to-severe asthma patients with initial biologic therapy between January 1, 2016, and April 30, 2020, in the Optum Clinformatics Data Mart was performed. Three administration settings were identified: Clinic-only (outpatient office/infusion center), Home (self-administration), and Hybrid setting (mixture of clinic and self-administration). Asthma biologic adherence was the proportion of observed over expected biologic dose administrations received within 6 months from initial therapy. Factors associated with adherence were identified by administration setting, using Poisson regression analyses. A relationship between a 1-year all-cause ED visit and adherence was assessed for each administration setting using Cox regression analyses. RESULTS: The study cohort was 3932 patients. Biologics adherence was 0.75 [0.5, 1] in Clinic setting, the most common administration setting, and 0.83 [0.5, 1] in both Home and Hybrid settings. Specialist access was consistently associated with better biologic adherence, whereas Black race, Hispanic ethnicity, lower education, Medicare only insurance, and higher patient out-of-pocket cost were associated with worse biologic adherence in some settings. In the Hybrid setting, hazard for a 1-year all-cause ED visit decreased with biologic adherence. CONCLUSIONS: Asthma biologic adherence varied by administration setting. Efforts to improve asthma biologic adherence should consider promoting self-administration when beneficial, improving prior specialist access, and targeting patients with higher risk of suboptimal adherence particularly Black and Hispanic patients.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Allergy Clin Immunol Pract

DOI

EISSN

2213-2201

Publication Date

September 2022

Volume

10

Issue

9

Start / End Page

2355 / 2366

Location

United States

Related Subject Headings

  • United States
  • Retrospective Studies
  • Medication Adherence
  • Medicare
  • Humans
  • Cohort Studies
  • Biological Products
  • Asthma
  • Aged
  • 3204 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Osazuwa-Peters, O. L., Greiner, M. A., Oberle, A., Oakes, M., Thomas, S. M., & Bosworth, H. (2022). Factors Related to Biologic Adherence and Outcomes Among Moderate-to-Severe Asthma Patients. J Allergy Clin Immunol Pract, 10(9), 2355–2366. https://doi.org/10.1016/j.jaip.2022.05.022
Osazuwa-Peters, Oyomoare L., Melissa A. Greiner, Amber Oberle, Megan Oakes, Sheila M. Thomas, and Hayden Bosworth. “Factors Related to Biologic Adherence and Outcomes Among Moderate-to-Severe Asthma Patients.J Allergy Clin Immunol Pract 10, no. 9 (September 2022): 2355–66. https://doi.org/10.1016/j.jaip.2022.05.022.
Osazuwa-Peters OL, Greiner MA, Oberle A, Oakes M, Thomas SM, Bosworth H. Factors Related to Biologic Adherence and Outcomes Among Moderate-to-Severe Asthma Patients. J Allergy Clin Immunol Pract. 2022 Sep;10(9):2355–66.
Osazuwa-Peters, Oyomoare L., et al. “Factors Related to Biologic Adherence and Outcomes Among Moderate-to-Severe Asthma Patients.J Allergy Clin Immunol Pract, vol. 10, no. 9, Sept. 2022, pp. 2355–66. Pubmed, doi:10.1016/j.jaip.2022.05.022.
Osazuwa-Peters OL, Greiner MA, Oberle A, Oakes M, Thomas SM, Bosworth H. Factors Related to Biologic Adherence and Outcomes Among Moderate-to-Severe Asthma Patients. J Allergy Clin Immunol Pract. 2022 Sep;10(9):2355–2366.
Journal cover image

Published In

J Allergy Clin Immunol Pract

DOI

EISSN

2213-2201

Publication Date

September 2022

Volume

10

Issue

9

Start / End Page

2355 / 2366

Location

United States

Related Subject Headings

  • United States
  • Retrospective Studies
  • Medication Adherence
  • Medicare
  • Humans
  • Cohort Studies
  • Biological Products
  • Asthma
  • Aged
  • 3204 Immunology